Suppr超能文献

伊朗东南部结直肠癌中K-RAS和N-RAS基因突变的频率

Frequency of K-RAS and N-RAS Gene Mutations in Colorectal Cancers in Southeastern Iran.

作者信息

Mohsen Naseri, Ahmadreza Sebzari, Fatemeh Haghighi, Fatemeh Hajipoor, Fariba Emadian Razavi

机构信息

Genomics Research Center, Paramedical Faculty, University of Medical Sciences, Birjand, Iran.

出版信息

Asian Pac J Cancer Prev. 2016 Jan 9;17(9):4511-4515.

Abstract

Background: K-RAS and N-RAS gene mutations cause resistance to treatment in patients with colorectal cancer. Based on this, awareness of mutation of these genes is considered a clinically important step towards better diagnosis and appropriate treatment. Materials and Methods: Fifty paraffin-embedded blocks of colorectal cancer were obtained from Imam Reza Hospital of Birjand, Iran. Following DNA extraction, the samples were analyzed for common mutations of exons 2, 3 and 4 of KRAS and NRAS genes using real time PCR and pyrosequencing. Results: According to this study, the prevalence of mutations was respectively 28% (14 out of 50) and 2% (1 out of 50) in KRAS and NRAS genes. All the mutations were observed in patients >50 years old. Conclusions: Mutations were found in both KRAS and NRAS genes in colorectal cancers in Iranian patients. Determining the frequency of these mutations in each geographical region may be necessary to benefit from targeted cancer therapy.

摘要

背景

K-RAS和N-RAS基因突变会导致结直肠癌患者产生治疗抗性。基于此,了解这些基因的突变情况被视为朝着更好诊断和恰当治疗迈出的重要临床一步。材料与方法:从伊朗比尔詹德的伊玛目礼萨医院获取了50个结直肠癌石蜡包埋组织块。提取DNA后,使用实时PCR和焦磷酸测序分析样本中KRAS和NRAS基因第2、3和4外显子的常见突变。结果:根据本研究,KRAS和NRAS基因的突变率分别为28%(50例中有14例)和2%(50例中有1例)。所有突变均见于年龄大于50岁的患者。结论:在伊朗患者的结直肠癌中发现了KRAS和NRAS基因的突变。为了从靶向癌症治疗中获益,可能有必要确定每个地理区域这些突变的频率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验